Literature DB >> 2052136

Foot-shock stress enhances the increase of [35S]TBPS binding in the rat cerebral cortex and the convulsions induced by isoniazid.

M Serra1, E Sanna, A Concas, C Foddi, G Biggio.   

Abstract

We report earlier that isoniazid and foot-shock stress individually increase the maximal number of [35S]TBPS binding sites (Bmax) measured "ex vivo" in unwashed membranes from rat cerebral cortex and that the increase due to both treatments are prevented by pretreatment "in vivo" with diazepam which alone induced a significant decrease in the total number of [35S]TBPS binding sites. In the present paper, the effect of stress was studied on both the increase in [35S]TBPS binding and the convulsant activity induced by isoniazid in unstressed rats. Isoniazid induced a time dependent increase in [35S]TBPS binding. The isoniazid-induced increase in [35S]TBPS binding was markedly potentiated by foot-shock stress. Moreover, foot-shock stress markedly reduced the latency to the appearance of generalized seizures induced by isoniazid (300 mg/kg s.c.). The results provide evidence that the "in vivo" inhibition of GABAergic transmission elicited by isoniazid results in an increase of [35S]TBPS binding in the rats cerebral cortex. The finding that stress, like isoniazid, enhances [35S]TBPS binding suggests that this treatment also inhibits the function of GABAergic synapses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052136     DOI: 10.1007/bf00965822

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

1.  Foot-shock stress and anxiogenic beta-carbolines increase t-[35S]butylbicyclophosphorothionate binding in the rat cerebral cortex, an effect opposite to anxiolytics and gamma-aminobutyric acid mimetics.

Authors:  A Concas; M Serra; T Atsoggiu; G Biggio
Journal:  J Neurochem       Date:  1988-12       Impact factor: 5.372

2.  Stress-induced changes in t-[35S]butylbicyclophosphorothionate binding to gamma-aminobutyric acid-gated chloride channels are mimicked by in vitro occupation of benzodiazepine receptors.

Authors:  R Trullas; H Havoundjian; P Skolnick
Journal:  J Neurochem       Date:  1987-09       Impact factor: 5.372

Review 3.  Electrophysiology of GABAA and GABAB receptor subtypes.

Authors:  J Bormann
Journal:  Trends Neurosci       Date:  1988-03       Impact factor: 13.837

Review 4.  The pharmacology of spinal postsynaptic inhibition.

Authors:  D R Curtis
Journal:  Prog Brain Res       Date:  1969       Impact factor: 2.453

5.  The action of stress, beta-carbolines, diazepam, and Ro 15-1788 on GABA receptors in the rat brain.

Authors:  G Biggio
Journal:  Adv Biochem Psychopharmacol       Date:  1983

6.  Ethyl-beta-carboline-3-carboxylate decreases [3H]GABA binding in membrane preparations of rat cerebral cortex.

Authors:  A Concas; M Salis; M Serra; M G Corda; G Biggio
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

7.  Modulation of the chloride ionophore by benzodiazepine receptor ligands: influence of gamma-aminobutyric acid and ligand efficacy.

Authors:  K W Gee; L J Lawrence; H I Yamamura
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

8.  Isoniazid, an inhibitor of GABAergic transmission, enhances [35S]TBPS binding in rat cerebral cortex.

Authors:  M Serra; E Sanna; G Biggio
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

9.  Regulation of [35S]t-butylbicyclophosphorothionate binding sites in rat brain by GABA, pyrethroid and barbiturate.

Authors:  J Seifert; J E Casida
Journal:  Eur J Pharmacol       Date:  1985-09-24       Impact factor: 4.432

10.  The effect of benzodiazepines and beta-carbolines on GABA-stimulated chloride influx by membrane vesicles from the rat cerebral cortex.

Authors:  T Obata; H I Yamamura
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

View more
  1 in total

Review 1.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.